[翻译文章] 在第三级医院授权非标签药物:五年前景
Lupe Rodríguez-de Francisco1, Ángela María Villalba-Moreno1, Eva Rocío Alfaro-Lara1
1Servicio de Farmacia, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
概括
对非标签药物使用的评估增加了四倍,由于缺乏替代品和有力的证据,大多数申请被批准. 这凸显了科学支持在管理这些特殊的治疗病例的关键需求.
科学领域:
- 药物经济学 药物经济学
- 临床药房 临床药房
- 使用药物使用药物使用.
背景情况:
- 非标签药物使用需要强有力的科学证据来证明风险/益处,特别是当没有替代品存在时.
- 本研究探讨了在第三级医院进行非标签药物使用评估的趋势和结果.
研究的目的:
- 分析非标签药物使用请求的模式,理由和经济影响,由药房和治疗委员会评估.
- 评估批准率和拒绝非标签药物申请的原因.
主要方法:
- 一项回顾性描述性研究分析了来自药房和治疗委员会 (2018-2022) 的124份报告.
- 数据包括药物申请,最终意见,证据水平和经济影响.
主要成果:
- 瘤血液学和自身免疫性疾病是非标签药物使用的主要迹象.
- 由于缺乏替代品和强有力的证据 (II-III阶段试验),观察到高的批准率 (74.2%).
- 已批准的药物带来了相当大的成本,如果被拒绝的治疗得到批准,可能会增加超过220万欧元的额外支出.
结论:
- 非标签药物使用评估增加了多达四倍,批准率始终很高.
- 这些发现强调了严格评估非标签药物使用的重要性,平衡治疗需求与经济考虑.
更多相关视频
相关概念视频
Prescription, Nonprescription and Orphan Drugs
1.2K
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
1.2K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
FDA Approved Drugs: Changes to Approved Drugs
236
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
236
Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K
Bioequivalence of Drugs: Drugs with Multiple Indications
144
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
144
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
225
Intermittent intravenous (IV) infusion is a method of drug administration where medications are delivered over short infusion periods followed by intervals of no drug delivery. This approach helps to prevent sustained high drug concentrations in the bloodstream, reducing the risk of adverse effects associated with prolonged exposure. Unlike continuous infusion, steady-state concentrations may not be achieved during a single dosing cycle but can be reached through repeated...
225


